Analysts Set The Clorox Company (NYSE:CLX) PT at $125.69

The Clorox Company (NYSE:CLX) has been given a consensus rating of “Reduce” by the eighteen analysts that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $125.6875.

CLX has been the topic of a number of research reports. Wells Fargo & Company cut their price objective on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. UBS Group set a $119.00 price target on shares of Clorox and gave the company a “neutral” rating in a report on Tuesday, November 4th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. JPMorgan Chase & Co. cut their target price on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group reduced their target price on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a report on Wednesday, October 1st.

Insider Activity

In related news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction dated Friday, November 21st. The stock was acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the purchase, the director owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.63% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Total Investment Management Inc. purchased a new stake in Clorox during the 2nd quarter worth $25,000. Center for Financial Planning Inc. acquired a new stake in shares of Clorox during the third quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of Clorox during the third quarter valued at about $25,000. American National Bank & Trust increased its position in shares of Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares during the last quarter. Finally, NewSquare Capital LLC lifted its stake in shares of Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Up 0.8%

Shares of CLX opened at $107.75 on Friday. Clorox has a fifty-two week low of $98.20 and a fifty-two week high of $171.37. The company’s fifty day moving average is $113.90 and its two-hundred day moving average is $121.57. The firm has a market cap of $13.14 billion, a PE ratio of 16.53, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the firm posted $1.86 EPS. The business’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts forecast that Clorox will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Wednesday, January 28th. Clorox’s payout ratio is currently 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.